• Japanese
  • Korean
  • Chinese
Cover Image

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market. The report provides market landscape, competitive landscape and market trends information on the vertebral augmentation and vertebroplasty devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, the UK, Germany, France, Italy, Spain and Japan.
  • Key segments covered include vertebral augmentation and vertebroplasty devices.
  • Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within vertebral augmentation and vertebroplasty devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, Stryker and CareFusion

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the vertebral augmentation and vertebroplasty devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the vertebral augmentation and vertebroplasty devices market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global vertebral augmentation and vertebroplasty devices market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Vertebral Compression Fractures - Overview

  • 3.1. Epidemiology
  • 3.2. Acute and Chronic Symptoms
  • 3.3. Treatment Options for VCF
    • 3.3.1. Benefits of Vertebral Augmentation over Vertebroplasty
    • 3.3.2. Potential Complications
  • 3.4. Treatment Flow Model for Vertebral Augmentation and Vertebroplasty Devices

4. Vertebral Augmentation and Vertebroplasty Devices: Global Market Characterization

  • 4.1. Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Historic, 2004-2011
  • 4.2. Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Forecast, 2011-2018
  • 4.3. Vertebral Augmentation and Vertebroplasty Devices Market, Key Trends
    • 4.3.1. Recovery of Kyphoplasty and Vertebroplasty Market from Negative Impact of New England Journal of Medicine Studies
    • 4.3.2. Niche Status of Vertebral Augmentation Market with High Growth and Low Competition Provides a Great Opportunity for Orthopedic Device Manufacturers
    • 4.3.3. Ongoing Studies Comparing the Effectiveness of Vertebral Augmentation and Vertebroplasty Techniques might decide the Course of Future Industry Growth
  • 4.4. Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics
    • 4.4.1. Market Drivers
    • 4.4.2. Market Restraints

5. Vertebral Augmentation and Vertebroplasty Devices Market, Analysis by Country, Revenue ($m), 2004 - 2018

  • 5.1. Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Historic, 2004-2011
  • 5.2. Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Forecast, 2011-2018
  • 5.3. Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Historic, 2004-2011
  • 5.4. Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Forecast, 2011-2018
  • 5.5. Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Historic, 2004-2011
  • 5.6. Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 5.7. Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Historic, 2004-2011
  • 5.8. Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Forecast, 2011-2018
  • 5.9. Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Historic, 2004-2011
  • 5.10. Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 5.11. Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Historic, 2004-2011
  • 5.12. Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 5.13. Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Historic, 2004-2011
  • 5.14. Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Forecast, 2011-2018

6. Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Competitive Assessment

  • 6.1. Vertebral Augmentation and Vertebroplasty Devices, Key Market Participants
    • 6.1.1. Medtronic Inc.
    • 6.1.2. Stryker Corporation
    • 6.1.3. CareFusion

7. Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products

  • 7.1. Confidence Spinal Cement System, Johnson & Johnson (DePuy/Synthes)
    • 7.1.1. Product Description
  • 7.2. Shield Kyphoplasty System, Soteira
    • 7.2.1. Product Description
  • 7.3. Kyphoplasty System, BONESUPPORT
    • 7.3.1. Product Description
  • 7.4. Acu-Cut Vertebral Augmentation System, Ascendx Spine
    • 7.4.1. Product Description
  • 7.5. V-MAX Delivery System, Johnson & Johnson (DePuy/Synthes)
    • 7.5.1. Product Description
  • 7.6. Integrated System for Vertebroplasty, Skeltex
    • 7.6.1. Product Description
  • 7.7. OsseoFix Spinal Fracture Reduction System, Alphatec Spine
    • 7.7.1. Product Description

8. Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products

  • 8.1. Crosstrees Pod, Crosstrees Medical Inc.
    • 8.1.1. Product Description
    • 8.1.2. Product Status
  • 8.2. Kiva VCF System, Benvenue Medical, Inc.
    • 8.2.1. Product Description
    • 8.2.2. Product Status
  • 8.3. OsseoFix Spinal Fracture Reduction System, Alphatec Spine, Inc.
    • 8.3.1. Product Description
    • 8.3.2. Product Status
  • 8.4. VerteLift Implant, SpineAlign Medical, Inc.
    • 8.4.1. Product Description
    • 8.4.2. Product Status
  • 8.5. AVAMAX Vertebroplasty Kits, CareFusion
    • 8.5.1. Product Description
    • 8.5.2. Product Status

9. Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Deals Analysis

  • 9.1. List of Venture Financing Deals
  • 9.2. List of Debt Offerings
  • 9.3. List of Partnership Deals
  • 9.4. List of Equity Offerings Deals
  • 9.5. Key Deals
    • 9.5.1. Ascendx Spine Entered into Co-Marketing Agreement with Anwerina
    • 9.5.2. Benvenue Medical Raised $25m Series D Financing
    • 9.5.3. Shanghai Kinetic Medical Completed IPO for $60m

10. Appendix

  • 10.1. Market Definitions
    • 10.1.1. Vertebral Augmentation and Vertebroplasty Devices
  • 10.2. Acronyms
  • 10.3. Sources
  • 10.4. Research Methodology
    • 10.4.1. Secondary Research
    • 10.4.2. Primary Research
    • 10.4.3. Models
    • 10.4.4. Forecasts
    • 10.4.5. Expert Panels
  • 10.5. GlobalData Consulting
  • 10.6. Contact Us
  • 10.7. Disclaimer

List of Tables

  • Table 1: VCF Prevalence in Cancer Patients
  • Table 2: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004-2011
  • Table 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011-2018
  • Table 4: Details of New England Journal of Medicine Studies on Vertebroplasty And Vertebral Augmentation Procedures, August 2009
  • Table 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008-2010
  • Table 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008-2011
  • Table 7: FREE (Fracture Reduction Evaluation), 2009
  • Table 8: FREE (Fracture Reduction Evaluation), 2011
  • Table 9: Cancer Patient Fracture Evaluation or CAFE, 2011
  • Table 10: Mortality Risk for Operated and Non-operated Vertebral Fracture Patients in the Medicare population or The SAVE study, 2011
  • Table 11: Three-year Outcomes after Kyphoplasty in Patients with Osteoporosis with Painful Vertebral Fractures , 2010
  • Table 12: Comparison of 5,766 Vertebral Compression Fractures Treated With or Without Kyphoplasty, 2010
  • Table 13: The Kiva System as a Vertebral Augmentation Treatment (KAST), Ongoing
  • Table 14: Balloon Kyphoplasty Versus Vertebroplasty for Treatment of Osteoporotic Vertebral Compression Fracture: a Prospective, Comparative and Randomized Clinical Study
  • Table 15: Adjacent Vertebral Fractures after Percutaneous Vertebral Augmentation of Osteoporotic Vertebral Compression Fracture: A Comparison of Balloon Kyphoplasty and Vertebroplasty, 2010
  • Table 16: Efficacy of Unipedicular Balloon Kyphoplasty for Treatment of Multiple Myeloma Vertebral Lesions, 2011
  • Table 17: Snapshot of New Diagnostic Technologies for Osteoporosis, 2010-2012
  • Table 18: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018
  • Table 19: Procedure Cost Comparison, Vertebroplasty vs. Vertebral Augmentation, the US, 2007-2008
  • Table 20: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011
  • Table 21: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004-2011
  • Table 22: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011-2018
  • Table 23: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004-2011
  • Table 24: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011-2018
  • Table 25: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004-2011
  • Table 26: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011-2018
  • Table 27: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004-2011
  • Table 28: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011-2018
  • Table 29: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004-2011
  • Table 30: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011-2018
  • Table 31: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($), 2004-2011
  • Table 32: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011-2018
  • Table 33: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004-2011
  • Table 34: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011-2018
  • Table 35: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011
  • Table 36: Medtronic, Key Marketed Products, 2012
  • Table 37: Kyphoplasty Settlements Between Hospitals and US Federal Government, 2009 - 2011
  • Table 38: Medtronic, Quarterly Revenue Decline from Core Spine, 2012
  • Table 39: Stryker, Key Marketed Products, 2012
  • Table 40: CareFusion, Key Marketed Products, 2012
  • Table 41: Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products
  • Table 42: Confidence Spinal Cement System, Description, 2011
  • Table 43: Shield Kyphoplasty System, Description, 2011
  • Table 44: Kyphoplasty System, Description, 2011
  • Table 45: Acu-Cut Vertebral Augmentation System, Description, 2011
  • Table 46: V-MAX Delivery System, Description, 2011
  • Table 47: Integrated System for Vertebroplasty (ISV), Description, 2011
  • Table 48: OsseoFix Spinal Fracture Reduction System, Description, 2010
  • Table 49: Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products
  • Table 50: Crosstrees Pod, Status
  • Table 51: Kiva VCF System, Status
  • Table 52: OsseoFix Spinal Fracture Reduction System, Status
  • Table 53: VerteLift Implant
  • Table 54: AVAMAX Vertebroplasty Kits, Status
  • Table 55: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010-2012
  • Table 56: Vertebral Augmentation and Vertebroplasty Devices Market, Venture Financing Deals, 2010-2012
  • Table 57: Vertebral Augmentation and Vertebroplasty Devices Market, Debt Offerings, 2010-2012
  • Table 58: Vertebral Augmentation and Vertebroplasty Devices Market, Partnership Deals, 2010-2012
  • Table 59: Vertebral Augmentation and Vertebroplasty Devices Market, Equity Offering Deals, 2012

List of Figures

  • Figure 1: Vertebral Compression Fracture, Treatment Options
  • Figure 2: Treatment Flow Model: Vertebral Augmentation and Vertebroplasty Devices, Global, 2010
  • Figure 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004-2011
  • Figure 4: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011-2018
  • Figure 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008-2010
  • Figure 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008-2011
  • Figure 7: Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics
  • Figure 8: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018
  • Figure 9: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011
  • Figure 10: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004-2011
  • Figure 11: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011-2018
  • Figure 12: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004-2011
  • Figure 13: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011-2018
  • Figure 14: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004-2011
  • Figure 15: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011-2018
  • Figure 16: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004-2011
  • Figure 17: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011-2018
  • Figure 18: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004-2011
  • Figure 19: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011-2018
  • Figure 20: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2004-2011
  • Figure 21: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011-2018
  • Figure 22: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004-2011
  • Figure 23: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011-2018
  • Figure 24: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011
  • Figure 25: Medtronic, SWOT Analysis
  • Figure 26: Medtronic, Quarterly Revenue Decline from Core Spine, 2012
  • Figure 27: Stryker, SWOT Analysis
  • Figure 28: CareFusion, SWOT Analysis
  • Figure 29: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010-2012
Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top